Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 19, 2021
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
Matthew Harrison Maintained (BMRN) at Hold with Decreased Target to $82 on, Apr 19th, 2021
Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Decreased Target from $85 to $82 on, Apr 19th, 2021.
Matthew has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, March 1st, 2021
- Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $91 on, Monday, March 1st, 2021
